rs267607894

Variant summary

Our verdict is Pathogenic. The variant received 22 ACMG points: 22P and 0B. PS3PM1PM2PM5PP3_StrongPP5_Very_Strong

The NM_000249.4(MLH1):​c.2246T>C​(p.Leu749Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000278167: Authors suggest the pathogenic effect of this mutation is due to direct interference with dimerization and severely compromised mismatch repair activity (Kosinski J et al. Hum Mutat. 2010 Aug" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L749V) has been classified as Likely pathogenic. The gene MLH1 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: not found (cov: 32)

Consequence

MLH1
NM_000249.4 missense

Scores

13
6

Clinical Significance

Pathogenic reviewed by expert panel P:13

Conservation

PhyloP100: 7.81

Publications

20 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet, Ambry Genetics
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000249.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 22 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000278167: Authors suggest the pathogenic effect of this mutation is due to direct interference with dimerization and severely compromised mismatch repair activity (Kosinski J et al. Hum Mutat. 2010 Aug; 31(8):975-82). In another study, cells with the MLH1 p.L749P pathogenic mutation had protein expression levels of greater than 70% when compared to wild-type; however the repair activity was less than 30% when compared to wild-type (Hinrichsen I et al. Clin Cancer Res. 2013 May; 19(9):2432-41).; SCV000905472: Functional studies have shown that this variant decreases protein stability and impairs DNA mismatch repair activity (PMID: 20533529, 22736432, 23403630, 28767177).; SCV000565172: Published functional studies demonstrate a damaging effect: reduced mismatch repair activity compared to wild-type and decreased PMS2 levels suggesting a defect in the MLH1-PMS2 heterodimer, with inconsistent results with respect to MLH1 protein expression (PMID: 20533529, 22736432, 23403630); SCV000543529: Experimental studies have shown that this missense change affects MLH1 function (PMID: 20533529, 22736432, 23403630).; SCV001550087: "The variant caused decreased co-expression of PMS2, which is unstable in the absence of interaction with MLH1, suggesting that this alteration may confer a pathogenic effect (Kosinski 2010, Borras 2012, Dudley 2015). The variant also severely compromised mismatch repair activity (Kosinski 2010)."; SCV002072850: Experimental studies have shown that this missense change affects MLH1 function (Kosinski et al., 2010; Borràs et al., 2012).; SCV004186498: Functional studies indicate this variant impacts protein function [PMID: 23403630, 22736432, 20533529].; SCV005338551: Functional studies have shown this variant negatively impacts protein function (Kosinski J et al. 2010. PubMed ID: 20533529; Hinrichsen I et al. 2013. PubMed ID: 23403630; Borràs E et al. 2012. PubMed ID: 22736432).
PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 34 uncertain in NM_000249.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-37050627-C-G is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 3635666.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.986
PP5
Variant 3-37050628-T-C is Pathogenic according to our data. Variant chr3-37050628-T-C is described in ClinVar as Pathogenic. ClinVar VariationId is 90097.Status of the report is reviewed_by_expert_panel, 3 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.2246T>Cp.Leu749Pro
missense
Exon 19 of 19NP_000240.1P40692-1
MLH1
NM_001354628.2
c.2153T>Cp.Leu718Pro
missense
Exon 18 of 18NP_001341557.1A0A087WX20
MLH1
NM_001354629.2
c.2147T>Cp.Leu716Pro
missense
Exon 18 of 18NP_001341558.1A0AAQ5BGZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000231790.8
TSL:1 MANE Select
c.2246T>Cp.Leu749Pro
missense
Exon 19 of 19ENSP00000231790.3P40692-1
MLH1
ENST00000456676.7
TSL:1
c.2039T>Cp.Leu680Pro
missense
Exon 17 of 17ENSP00000416687.3H0Y818
MLH1
ENST00000413740.2
TSL:1
c.1810T>Cp.Tyr604His
missense
Exon 15 of 15ENSP00000416476.2H0Y806

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00000534
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
Colorectal cancer, hereditary nonpolyposis, type 2 (3)
3
-
-
not provided (3)
2
-
-
Hereditary cancer-predisposing syndrome (2)
1
-
-
Carcinoma of colon (1)
1
-
-
Hereditary nonpolyposis colorectal neoplasms (1)
1
-
-
Inherited MMR deficiency (Lynch syndrome) (1)
1
-
-
Lynch syndrome (1)
1
-
-
MLH1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.54
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.94
D
Eigen
Uncertain
0.58
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.49
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Uncertain
0.45
D
MutationAssessor
Pathogenic
3.8
H
PhyloP100
7.8
PrimateAI
Uncertain
0.78
T
PROVEAN
Pathogenic
-6.8
D
REVEL
Pathogenic
0.98
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.99
gMVP
0.96
Mutation Taster
=5/95
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs267607894;
hg19: chr3-37092119;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.